News items related to: News
-
Thai civil society opposes patent on an influenza drug, now used for COVID-19
Favipiravir, originally approved as an influenza drug, is being used to treat COVID-19 patients with pneumonia, alongside anti-malarial and anti-retroviral...
-
Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
This week, civil society in Morocco has called for the urgent removal of unnecessary legal barriers, which are “tailor-made for...
-
Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
Humanitarian Action with technical support from ITPCru has opposed Gilead’s patent in Russia for the combination of two antiretroviral drugs,...
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
Dolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
-
New data: Treat HIV for just four weeks of global pharmaceutical sales
The Make Medicines Affordable campaign is calling for a widespread switch from patented to generic HIV drugs so that at...
-
AIDS 2020 leadership workshop: Strategies for lowering drug prices
Activists, policy-makers, researchers and healthcare providers joined a leadership workshop led by ITPC’s Make Medicines Affordable campaign at AIDS 2020...
-
COVID-19: Another of Gilead’s FIVE patent applications on remdesivir is opposed in Argentina
Our campaign partner, Fundación GEP, has filed a second patent opposition against one of Gilead’s numerous patent applications for the...
-
AIDS 2020 exhibition: Love, life and riots
We’re exhibiting at #AIDS2020Virtual, the world’s largest virtual AIDS conference. Our photo exhibition Love, Life and Riots will be on...
-
What’s on: AIDS 2020 Virtual for treatment activists
Kicking off on Monday 6 July, with a workshop on innovative strategies to reduce prohibitive drug prices, we’ve compiled some...
-
Ukraine: 100% LIFE opposes patent on TB drug for children
Our campaign partner in Ukraine, 100% LIFE, has submitted the first patent opposition on bedaquiline in the Eastern Europe and Central...
-
Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
Our partner, Fundación GEP, has filed a patent opposition against Gilead’s patent application on remdesivir before the Argentinean Patent Office....
-
COVID-19: Local manufacturing essential if we are to “treat all”
ITPC led a virtual roundtable last week (26 May 2020) attended by civil society treatment experts, researchers, and national pharmaceutical...